-
Jug r 2-reactive CD4(+) T cells have a dominant immune role in walnut allergy.
J Allergy Clin ImmunolArchila LD, Jeong D, Pascal M, Bartra J, Juan M, Robinson D, Farrington ML, Kwok WW -
Inhibition of hyaluronan synthesis restores immune tolerance during autoimmune insulitis.
J Clin InvestNagy N, Kaber G, Johnson PY, Gebe JA, Preisinger A, Falk BA, Sunkari VG, Gooden MD, Vernon RB, Bogdani M, Kuipers HF, Day AJ, Campbell DJ, Wight TN, Bollyky PL -
Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report.
Diabetes CareWherrett DK, Chiang JL, Delamater AM, DiMeglio LA, Gitelman SE, Gottlieb PA, Herold KC, Lovell DJ, Orchard TJ, Ryan CM, Schatz DA, Wendler DS, Greenbaum CJ, Type 1 Diabetes TrialNet Study Group. -
Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association.
Diabetes CareInsel RA, Dunne JL, Atkinson MA, Chiang JL, Dabelea D, Gottlieb PA, Greenbaum CJ, Herold KC, Krischer JP, Lernmark A, Ratner RE, Rewers MJ, Schatz DA, Skyler JS, Sosenko JM, Ziegler AG -
The Relationship of Immune Cell Signatures to Patient Survival Varies within and between Tumor Types.
PLoS OneLinsley PS, Chaussabel D, Speake C -
Control of Regulatory T Cell Migration, Function, and Homeostasis.
J ImmunolCampbell DJ -
Stress Testing of an Artificial Pancreas System With Pizza and Exercise Leads to Improvements in the System's Fuzzy Logic Controller.
J Diabetes Sci TechnolMauseth R, Lord SM, Hirsch IB, Kircher RC, Matheson DP, Greenbaum CJ -
Heterogeneity in recent-onset type 1 diabetes - a clinical trial perspective.
Diabetes Metab Res RevBollyky JB, Xu P, Butte AJ, Wilson DM, Beam CA, Greenbaum CJ, Type 1 Diabetes TrialNet Study Group. -
Expression of V3 Versican by Rat Arterial Smooth Muscle Cells Promotes Differentiated and Anti-inflammatory Phenotypes.
J Biol ChemKang I, Barth JL, Sproul EP, Yoon DW, Workman GA, Braun KR, Argraves WS, Wight TN -
Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease.
PLoS OneLord JD, Shows DM, Chen J, Thirlby RC -
Factor VIII gene variants and inhibitor risk in African American hemophilia A patients.
BloodGunasekera D, Ettinger RA, Nakaya Fletcher S, James EA, Liu M, Barrett JC, Withycombe J, Matthews DC, Epstein MS, Hughes RJ, Pratt KP, Personalized Approaches to Therapies for Hemophilia (PATH) Study Investigators. -
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.
J Clin InvestRigby MR, Harris KM, Pinckney A, DiMeglio LA, Rendell MS, Felner EI, Dostou JM, Gitelman SE, Griffin KJ, Tsalikian E, Gottlieb PA, Greenbaum CJ, Sherry NA, Moore WV, Monzavi R, Willi SM, Raskin P, Keyes-Elstein L, Long SA, Kanaparthi S, Lim N, Phippard D, Soppe CL, Fitzgibbon ML, McNamara J, Nepom GT, Ehlers MR -
Natural progression of atherosclerosis from pathologic intimal thickening to late fibroatheroma in human coronary arteries: A pathology study.
AtherosclerosisOtsuka F, Kramer MC, Woudstra P, Yahagi K, Ladich E, Finn AV, de Winter RJ, Kolodgie FD, Wight TN, Davis HR, Joner M, Virmani R -
Hyaluronan: A Mediator of Islet Dysfunction and Destruction in Diabetes?
J Histochem CytochemHull RL, Bogdani M, Nagy N, Johnson PY, Wight TN -
Disease modifying therapies in type 1 diabetes: Where have we been, and where are we going?
Pharmacol ResLord S, Greenbaum CJ
